+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Somatostatin Analogs Market Intelligence Report - Global Forecast to 2027

  • PDF Icon

    Report

  • 113 Pages
  • July 2022
  • Region: Global
  • Think Market Intelligence
  • ID: 5624263
UP TO OFF until Dec 31st 2022
The Global Somatostatin Analogs Market is projected to reach USD 10,060.51 million by 2027 from USD 5,608.29 million in 2021, at a CAGR 10.22% during the forecast period.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas Somatostatin Analogs Market size was estimated at USD 1,721.50 million in 2021, is expected to reach USD 1,902.95 million in 2022, and is projected to grow at a CAGR of 10.38% to reach USD 3,115.11 million by 2027.
  • The Asia-Pacific Somatostatin Analogs Market size was estimated at USD 1,455.58 million in 2021, is expected to reach USD 1,607.02 million in 2022, and is projected to grow at a CAGR of 10.34% to reach USD 2,627.54 million by 2027.
  • The Europe, Middle East & Africa Somatostatin Analogs Market size was estimated at USD 2,431.20 million in 2021, is expected to reach USD 2,662.07 million in 2022, and is projected to grow at a CAGR of 10.04% to reach USD 4,317.85 million by 2027.

Market Segmentation & Coverage:


The report on somatostatin analogs identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. This market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the somatostatin analogs to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

  • Lanreotide
  • Octreotide
  • Pasireotide

Application:

  • Acromegaly
  • Neuroendocrine Tumors

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Colorado
      • Florida
      • Illinois
      • Minnesota
      • New York
      • North Carolina
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa
    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Amryt Pharma plc
  • Camurus AB
  • Crinetics Pharmaceuticals, Inc.
  • CVS Health Corporation
  • Dauntless Pharmaceuticals, Inc.
  • Fresenius SE & Co. KGaA
  • Hybio Pharmaceutical Co., Ltd.
  • Ipsen Pharma
  • Merck KGaA
  • Midatech Pharma PLC
  • Novartis International AG
  • Peptron, Inc.
  • Pfizer Inc.
  • Recordati Rare Diseases, Inc.
  • Sun Pharmaceutical Industries Limited
  • Teijin Limited
  • Teva Pharmaceuticals Inc.
  • Viatris Inc.
Frequently Asked Questions about the Somatostatin Analogs Market

What is the estimated value of the Somatostatin Analogs Market?

The Somatostatin Analogs Market was estimated to be valued at $5608.29 Million in 2021.

What is the growth rate of the Somatostatin Analogs Market?

The growth rate of the Somatostatin Analogs Market is 10.2%, with an estimated value of $10060.51 Million by 2027.

What is the forecasted size of the Somatostatin Analogs Market?

The Somatostatin Analogs Market is estimated to be worth $10060.51 Million by 2027.

Who are the key companies in the Somatostatin Analogs Market?

Key companies in the Somatostatin Analogs Market include Amryt Pharma plc, Camurus AB, Crinetics Pharmaceuticals, Inc., CVS Health Corporation, Dauntless Pharmaceuticals, Inc., Fresenius SE & Co. KGaA, Hybio Pharmaceutical Co., Ltd., Ipsen Pharma and Midatech Pharma PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Americas Somatostatin Analogs Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States
5. Asia-Pacific Somatostatin Analogs Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand
6. Europe, Middle East & Africa Somatostatin Analogs Market
6.1. Introduction
6.2. France
6.3. Germany
6.4. Italy
6.5. Netherlands
6.6. Qatar
6.7. Russia
6.8. Saudi Arabia
6.9. South Africa
6.10. Spain
6.11. United Arab Emirates
6.12. United Kingdom
7. Company Usability Profiles
7.1. Amryt Pharma plc
7.2. Camurus AB
7.3. Crinetics Pharmaceuticals, Inc.
7.4. CVS Health Corporation
7.5. Dauntless Pharmaceuticals, Inc.
7.6. Fresenius SE & Co. KGaA
7.7. Hybio Pharmaceutical Co., Ltd.
7.8. Ipsen Pharma
7.9. Merck KGaA
7.10. Midatech Pharma PLC
7.11. Novartis International AG
7.12. Peptron, Inc.
7.13. Pfizer Inc.
7.14. Recordati Rare Diseases, Inc.
7.15. Sun Pharmaceutical Industries Limited
7.16. Teijin Limited
7.17. Teva Pharmaceuticals Inc.
7.18. Viatris Inc.
List of Figures
Figure 1. Global Somatostatin Analogs Market: Research Process
Figure 2. Global Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 3. Global Somatostatin Analogs Market Size, by Region, 2021 Vs 2027 (%)
Figure 4. Global Somatostatin Analogs Market Size, by Region, 2021 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For Global Somatostatin Analogs Market Size, by Region, 2027
Figure 6. Americas Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 7. Americas Somatostatin Analogs Market Size, by Country, 2021 Vs 2027 (%)
Figure 8. Americas Somatostatin Analogs Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 9. Competitive Strategic Window For Americas Somatostatin Analogs Market Size, by Country, 2027
Figure 10. Argentina Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 11. Brazil Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 12. Canada Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 13. Mexico Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 14. United States Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 15. United States Somatostatin Analogs Market Size, by State, 2021 Vs 2027 (%)
Figure 16. United States Somatostatin Analogs Market Size, by State, 2021 Vs 2027 (USD Million)
Figure 17. Competitive Strategic Window For United States Somatostatin Analogs Market Size, by State, 2027
Figure 18. Asia-Pacific Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 19. Asia-Pacific Somatostatin Analogs Market Size, by Country, 2021 Vs 2027 (%)
Figure 20. Asia-Pacific Somatostatin Analogs Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 21. Competitive Strategic Window For Asia-Pacific Somatostatin Analogs Market Size, by Country, 2027
Figure 22. Australia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 23. China Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 24. India Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 25. Indonesia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 26. Japan Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 27. Malaysia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 28. Philippines Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 29. Singapore Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 30. South Korea Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 31. Taiwan Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 32. Thailand Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 33. Europe, Middle East & Africa Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 34. Europe, Middle East & Africa Somatostatin Analogs Market Size, by Country, 2021 Vs 2027 (%)
Figure 35. Europe, Middle East & Africa Somatostatin Analogs Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 36. Competitive Strategic Window For Europe, Middle East & Africa Somatostatin Analogs Market Size, by Country, 2027
Figure 37. France Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 38. Germany Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 39. Italy Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 40. Netherlands Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 41. Qatar Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 42. Russia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 43. Saudi Arabia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 44. South Africa Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 45. Spain Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 46. United Arab Emirates Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Figure 47. United Kingdom Somatostatin Analogs Market Size, 2019-2027 (USD Million)
List of Tables
Table 1. Global Somatostatin Analogs Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 4. Global Somatostatin Analogs Market Size, by Region, 2019-2027 (USD Million)
Table 5. Global Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 6. Global Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 7. Americas Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 8. Americas Somatostatin Analogs Market Size, by Country, 2019-2027 (USD Million)
Table 9. Americas Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 10. Americas Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 11. Argentina Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 12. Argentina Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 13. Argentina Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 14. Brazil Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 15. Brazil Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 16. Brazil Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 17. Canada Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 18. Canada Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 19. Canada Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 20. Mexico Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 21. Mexico Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 22. Mexico Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 23. United States Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 24. United States Somatostatin Analogs Market Size, by State, 2019-2027 (USD Million)
Table 25. United States Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 26. United States Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 27. Asia-Pacific Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 28. Asia-Pacific Somatostatin Analogs Market Size, by Country, 2019-2027 (USD Million)
Table 29. Asia-Pacific Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 30. Asia-Pacific Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 31. Australia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 32. Australia Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 33. Australia Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 34. China Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 35. China Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 36. China Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 37. India Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 38. India Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 39. India Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 40. Indonesia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 41. Indonesia Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 42. Indonesia Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 43. Japan Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 44. Japan Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 45. Japan Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 46. Malaysia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 47. Malaysia Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 48. Malaysia Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 49. Philippines Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 50. Philippines Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 51. Philippines Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 52. Singapore Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 53. Singapore Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 54. Singapore Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 55. South Korea Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 56. South Korea Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 57. South Korea Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 58. Taiwan Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 59. Taiwan Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 60. Taiwan Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 61. Thailand Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 62. Thailand Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 63. Thailand Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 64. Europe, Middle East & Africa Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 65. Europe, Middle East & Africa Somatostatin Analogs Market Size, by Country, 2019-2027 (USD Million)
Table 66. Europe, Middle East & Africa Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 67. Europe, Middle East & Africa Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 68. France Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 69. France Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 70. France Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 71. Germany Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 72. Germany Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 73. Germany Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 74. Italy Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 75. Italy Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 76. Italy Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 77. Netherlands Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 78. Netherlands Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 79. Netherlands Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 80. Qatar Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 81. Qatar Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 82. Qatar Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 83. Russia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 84. Russia Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 85. Russia Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 86. Saudi Arabia Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 87. Saudi Arabia Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 88. Saudi Arabia Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 89. South Africa Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 90. South Africa Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 91. South Africa Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 92. Spain Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 93. Spain Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 94. Spain Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 95. United Arab Emirates Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 96. United Arab Emirates Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 97. United Arab Emirates Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)
Table 98. United Kingdom Somatostatin Analogs Market Size, 2019-2027 (USD Million)
Table 99. United Kingdom Somatostatin Analogs Market Size, by Type, 2019-2027 (USD Million)
Table 100. United Kingdom Somatostatin Analogs Market Size, by Application, 2019-2027 (USD Million)

Companies Mentioned

  • Amryt Pharma plc
  • Camurus AB
  • Crinetics Pharmaceuticals, Inc.
  • CVS Health Corporation
  • Dauntless Pharmaceuticals, Inc.
  • Fresenius SE & Co. KGaA
  • Hybio Pharmaceutical Co., Ltd.
  • Ipsen Pharma
  • Merck KGaA
  • Midatech Pharma PLC
  • Novartis International AG
  • Peptron, Inc.
  • Pfizer Inc.
  • Recordati Rare Diseases, Inc.
  • Sun Pharmaceutical Industries Limited
  • Teijin Limited
  • Teva Pharmaceuticals Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...